Bibliographical noteFunding Information: The work was funded by the Prince Mahidol Award Foundation, Thai Health Promotion Foundation, and International Decision
Support Initiative. The Health Intervention and Technology Assessment Program (HITAP) is funded by the Thailand Research Fund (TRF) under a grant for senior research scholar (RTA5980011). HITAP’s International Unit is supported by the International Decision Support Initiative (iDSI) , which is funded by the Bill and Melinda Gates Foundation, the UK’s Department for International Development, and the Rockefeller Foundation. The findings, interpretations, and conclusions expressed in this article do not necessarily reflect the views of the funding agencies.
This article is part of a series commissioned by The BMJ. Open access fees are paid for by the Bill and Melinda Gates Foundation, which had no involvement
in the commissioning, peer review, or decision to publish.
Open Access: This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
Publisher Copyright: BMJ. Protected by copyright.
Citation: Isaranuwatchai W, Teerawattananon Y, Archer R A, Luz A, Sharma M, Rattanavipapong W et al. Prevention of non-communicable disease: best buys, wasted buys, and contestable buys BMJ 2020; 368 :m141